Paper4134064
Activation of the alternate pathway of human complements by rabbit cells.
Platts-Mills TA and 1 other. J Immunol, 1974. Cited by 544 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Activation of the alternate pathway of human complements by rabbit cells. Papers, record 4134064. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4134064
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Complement System Proteins | Major topic |
| Lymphocytes | Major topic |
| Acetates | |
| Animals | |
| Binding Sites, Antibody | |
| Erythrocytes | |
| Ethylenes | |
| Glycols | |
| Guinea Pigs | |
| Hemadsorption | |
| Hemagglutination Tests | |
| Hemolysis | |
| Humans | |
| Immune Adherence Reaction | |
| Iodine Radioisotopes | |
| Protein Denaturation | |
| Rabbits | |
| Radioimmunoassay | |
| Sheep | |
| gamma-Globulins |
Source PubMed
Cited by151
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 544 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39,875,346 | Seventy Years Later: Systemic and Local Properdin in Atherosclerosis. | J Am Heart Assoc | 2025 | https://conductscience.org/library/papers/39875346 | PubMed |
| 38,638,432 | Cutting edge of genetically modified pigs targeting complement activation for xenotransplantation. | Front Immunol | 2024 | https://conductscience.org/library/papers/38638432 | PubMed |
| 37,817,009 | Functional similarity of ABP 959 and eculizumab in simulated serum models of aHUS and NMOSD. | Ann Hematol | 2023 | https://conductscience.org/library/papers/37817009 | PubMed |
| 37,662,914 | Properdin inhibition ameliorates hepatic ischemia/reperfusion injury without interfering with liver regeneration in mice. | Front Immunol | 2023 | https://conductscience.org/library/papers/37662914 | PubMed |
| 36,330,514 | Pitfalls in complement analysis: A systematic literature review of assessing complement activation. | Front Immunol | 2022 | https://conductscience.org/library/papers/36330514 | PubMed |
| 35,493,497 | Ex Vivo Test for Measuring Complement Attack on Endothelial Cells: From Research to Bedside. | Front Immunol | 2022 | https://conductscience.org/library/papers/35493497 | PubMed |
| 35,387,017 | Lessons in Innate and Allergic Immunity From Dust Mite Feces and Tick Bites. | Front Allergy | 2021 | https://conductscience.org/library/papers/35387017 | PubMed |
| 33,847,933 | Functional Hemolytic Test for Complement Alternative Pathway Convertase Activity. | Methods Mol Biol | 2021 | https://conductscience.org/library/papers/33847933 | PubMed |
| 33,847,931 | Sheep Erythrocyte Preparation for Hemolytic Tests Exploring Complement Functional Activities. | Methods Mol Biol | 2021 | https://conductscience.org/library/papers/33847931 | PubMed |
| 33,006,965 | Modeling the activation of the alternative complement pathway and its effects on hemolysis in health and disease. | PLoS Comput Biol | 2020 | https://conductscience.org/library/papers/33006965 | PubMed |
| 31,787,968 | Current and Future Approaches for Monitoring Responses to Anti-complement Therapeutics. | Front Immunol | 2019 | https://conductscience.org/library/papers/31787968 | PubMed |
| 31,405,955 | Underlying Glycans Determine the Ability of Sialylated Lipooligosaccharide To Protect Nontypeable Haemophilus influenzae from Serum IgM and Complement. | Infect Immun | 2019 | https://conductscience.org/library/papers/31405955 | PubMed |
| 31,157,175 | Suppression of Alternative Lipooligosaccharide Glycosyltransferase Activity by UDP-Galactose Epimerase Enhances Murine Lung Infection and Evasion of Serum IgM. | Front Cell Infect Microbiol | 2019 | https://conductscience.org/library/papers/31157175 | PubMed |
| 30,405,598 | Interpretation of Serological Complement Biomarkers in Disease. | Front Immunol | 2018 | https://conductscience.org/library/papers/30405598 | PubMed |
| 27,799,929 | The High Prevalence of Functional Complement Defects Induced by Chemotherapy. | Front Immunol | 2016 | https://conductscience.org/library/papers/27799929 | PubMed |
| 25,841,549 | Anaphylaxis to the carbohydrate side chain alpha-gal. | Immunol Allergy Clin North Am | 2015 | https://conductscience.org/library/papers/25841549 | PubMed |
| 24,194,425 | Complement lesions in cell membranes from joint effusions of various types of arthritis. | Inflammation | 1976 | https://conductscience.org/library/papers/24194425 | PubMed |
| 23,227,092 | Complement diagnostics: concepts, indications, and practical guidelines. | Clin Dev Immunol | 2012 | https://conductscience.org/library/papers/23227092 | PubMed |
| 23,137,394 | Autoregulation of thromboinflammation on biomaterial surfaces by a multicomponent therapeutic coating. | Biomaterials | 2013 | https://conductscience.org/library/papers/23137394 | PubMed |
| 22,414,497 | Virulence of Streptococcus pneumoniae serotype 6C in experimental otitis media. | Microbes Infect | 2012 | https://conductscience.org/library/papers/22414497 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4134064
GET https://conductscience.org/api/papers/v1/4134064/cited_by?page=2